Atlas Trials

Parkinson's Disease

1,271 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Parkinson's Disease

RecordFirmDate
Clinical Trial on the Effectiveness of Herbal Medicinal Mixture in Parkinson Disease (NCT00656253)Fudan University2008-08-01
Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off (NCT00601978)Novartis Pharmaceuticals2008-08-01
Neuropsychiatric Effects of Deep Brain Stimulation in Patients With Parkinson's Disease (NCT01306539)University of California, San Diego2008-07-01
Botulinum A Toxin in Patients With Parkinson's Disease (NCT00822913)University Of Perugia2008-06-01
Deep Brain Stimulation and Digestive Symptomatology (NCT00639275)University Hospital, Rouen2008-06-01
Vitamin B6, B12, Folic Acid and Exercise in Parkinson's Disease (NCT01238926)New York Institute of Technology2008-05-01
Far Infrared Irradiation for Management and Treating of Parkinson's Disease (PD) (NCT00674895)GAAD Medical Research Institute Inc.2008-05-01
Clinical, Molecular and by Neuroimaging of LRRK2 Mutations (NCT01085227)Institut National de la Santé Et de la Recherche Médicale, France2008-04-01
The Effect of High-Volume Walking With Visual Cues (VC) in Parkinson´s Disease (PD) (NCT01391741)University of Iceland2008-04-01
Evaluation of Long-term Effect of Resonator Therapy on Parkinson's Disease (PD) (NCT00862537)pico-tesla Magnetic Therapies, LLC2008-04-01
Repetitive Transcranial Stimulation (r-TMS) Treatment for Patients With Parkinson's Disease (NCT00625300)Sheba Medical Center2008-04-01
Study to Evaluate SYN115 in Parkinson's Disease (NCT00605553)Biotie Therapies Inc.2008-04-01
Parkinson's Disease Isradipine Safety Study (NCT00753636)Northwestern University2008-04-01
Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off (NCT00642356)Novartis2008-03-01
SEDPARK2: Post Marketing Surveillance to Observe Safety and Efficacy of Piribedil in Parkinson's Disease (PIR-002/K) (NCT00727727)Desitin Arzneimittel GmbH2008-03-01
Psychoeducational Programme for PD Patients With STN-DBS (NCT02554370)Groupe Hospitalier Pitie-Salpetriere2008-02-01
Parkinson's Disease Genetics Database (NCT00855556)Northwell Health2008-02-01
A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients (NCT01628965)Otsuka Pharmaceutical Co., Ltd.2008-01-01
Treating H. Pylori in Parkinson's Patients With Motor Fluctuations (NCT00664209)University of California, Los Angeles2008-01-01
Dexmedetomidine Effects on Microelectrode Recording in Deep Brain Stimulation (NCT00608231)Vanderbilt University2008-01-01
Phase I/II Study of the Safety, Efficacy and Dose Evaluation of ProSavin for the Treatment of Bilateral Idiopathic Parkinson's Disease (NCT00627588)Oxford BioMedica2008-01-01
PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride Binding (NCT00562198)Orion Corporation, Orion Pharma2008-01-01
Methylphenidate for the Treatment of Gait Impairment in Parkinson's Disease (NCT00526630)University of Cincinnati2007-12-01
Keppra IV for the Treatment of Motor Fluctuations in Parkinson's Disease (NCT00584025)University of South Florida2007-12-01
Motor Cortex Stimulation for Parkinson's Disease (NCT00637260)Catholic University, Italy2007-12-01
Treadmill in the Rehabilitation of Parkinsonian Gait (NCT03815409)IRCCS National Neurological Institute "C. Mondino" Foundation2007-11-15
Solifenacin Succinate (VESIcare) for the Treatment of Urinary Incontinence in Parkinson's Disease (NCT00584090)University of South Florida2007-11-01
Phase 2 Clinical Study of KW-6500 in Parkinson's Disease Patients With Motor Response Complication on Levodopa Therapy (NCT00610103)Kyowa Kirin Co., Ltd.2007-11-01
Long-Term Effects of Amantadine in Parkinsonian (AMANDYSK) (NCT00632762)University Hospital, Toulouse2007-11-01
Light Therapy Treatment in Parkinson's Disease Patients With Daytime Somnolence (NCT01338649)Northwestern University2007-11-01
Effects of Virtual Reality Training in Patients With Parkinson's Disease (NCT01301651)National Taiwan University Hospital2007-11-01
Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's Disease (NCT00558337)Osmotica Pharmaceutical US LLC2007-11-01
The Effect of Exercise on Individuals With Parkinson's Disease (NCT00591344)University of Illinois at Chicago2007-10-01
Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's Disease (NCT00559871)Juvantia Pharma Ltd2007-10-01
Dose Range Finding Study of BF2.649 Versus Placebo to Treat Excessive Daytime Sleepiness in Parkinson's Disease Patients (NCT00642928)Bioprojet2007-10-01
Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients, and Safety in Combination With L-dopa (NCT00582673)Novartis2007-10-01
Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECT (NCT00566462)Eisai Inc.2007-10-01
Body Weight Gain, Parkinson, Subthalamic Stimulation (NCT00529724)University Hospital, Clermont-Ferrand2007-09-03
Apomorphine Effect on Nociceptive Perception in Parkinson's: a Clinical and Imaging Study (NCT00524914)University Hospital, Toulouse2007-09-01
Increased Gut Permeability to Lipopolysaccharides (LPS) in Parkinson's Disease (NCT01155492)Rush University Medical Center2007-09-01
A Pilot, Randomized Controlled Trial of Group Visits for Persons With Parkinson's Disease (NCT00528086)University of Rochester2007-09-01
Cognitive Impairment in Parkinson's Disease Categorised in Accordance to Motor Symptoms (NCT00476372)University of Aarhus2007-08-01
Treadmill Training and Quality of Life in Parkinson's Disease (NCT00890669)Universidade Federal de Sao Carlos2007-08-01
18-month Study of Long-term Efficacy & Safety of Safinamide as add-on Therapy in Patients With Mid-late Stage PD (NCT01286935)Newron Pharmaceuticals SPA2007-08-01
Reduction of Falls in the Elderly - Parkinson's Disease (NCT00518648)Radboud University Medical Center2007-08-01
Integrated Multidisciplinary Care for Parkinson's Disease: a Controlled Trial (NCT00518791)Radboud University Medical Center2007-08-01
Study of Magnetic Fields for Treatment of Parkinson's Disease (NCT00779155)pico-tesla Magnetic Therapies, LLC2007-08-01
Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease (NCT00623363)Daiichi Sankyo2007-07-13
Long-term Extension of RECOVER- Long-term Effect of the 24h Transdermal Delivery of Rotigotine in Subjects With Idiopathic Parkinson's Disease (NCT00519532)UCB Pharma2007-07-01
Deep Brain Stimulation in Patients With Parkinson's Disease (NCT00586079)Mayo Clinic2007-07-01
Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine (NCT00593606)UCB Pharma2007-07-01
Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal Patch (NCT00522379)UCB Pharma2007-07-01
Cognitive Benefits of Treating Sleep Apnea in Parkinson's Disease (NCT00492115)University of California, San Diego2007-07-01
Evaluation of the Long-term Safety, Tolerability, and Efficacy of Perampanel (E2007) as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Subjects With Motor Fluctuations (NCT00505622)Eisai Limited2007-07-01
Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's Disease (NCT00462254)Southern California Institute for Research and Education2007-06-01
Clinical Effects of Vitamin D Repletion in Patients With Parkinson's Disease (NCT00571285)Emory University2007-06-01
The Effects of Rasagiline on Cognitive Deficits Associated With Parkinson's Disease (NCT00696215)Istanbul University2007-06-01
REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 Study (NCT00485069)GlaxoSmithKline2007-06-01
Enteric Nervous System in Parkinson's Disease (NCT00491062)Nantes University Hospital2007-06-01
A Study of MK0657 in Parkinson's Disease Patients (0657-006) (NCT00505843)Merck Sharp & Dohme LLC2007-05-01
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine (NCT00474058)UCB Pharma2007-05-01
Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment (NCT00489255)Ipsen2007-05-01
Coping With Depression in Parkinson's Disease (NCT00464464)Rutgers, The State University of New Jersey2007-04-01
Psychosocial Treatment of Depression in Parkinson's Disease (NCT00853346)Amy Farabaugh, PhD2007-04-01
Caffeine for Excessive Daytime Somnolence in Parkinson's Disease (NCT00459420)Ron Postuma2007-04-01
Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Apathy in Parkinson's Disease (NCT00955032)University of Florida2007-04-01
Dose-Finding Safety Study of BIIB014 in Combination With Levodopa in Moderate to Late Stage Parkinson's Disease (NCT00438607)Biogen2007-04-01
A Phase 2b Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa (NCT00455507)Kyowa Kirin Co., Ltd.2007-03-01
NET-PD LS-1 Creatine in Parkinson's Disease (NCT00449865)University of Rochester2007-03-01
The Effect Of E2007 On Pharmacodynamic Responses To Levodopa Among Patients With Parkinson's Disease Who Experience Dyskinesia And Motor Fluctuations (NCT00451633)Eisai Inc.2007-03-01
Phase IIa Multicentre Study Investigating of VR040 in Parkinson's Disease (NCT01693081)South Glasgow University Hospitals NHS Trust2007-03-01
Sequence Effect in Parkinson's Disease (NCT00431366)National Institute of Neurological Disorders and Stroke (NINDS)2007-02-01
A Study of E2007 In Patients With Parkinson's Disease (NCT00427011)Eisai Inc.2007-02-01
The Association Between Dopamine Agonists and Cardiac Valvulopathy, Fibrosis and Other Cardiopulmonary Events (NCT01052948)Pfizer2007-01-01
Efficacy and Safety of Safinamide (50 and 100mg/Day) Versus Placebo, in Patients With Mid-late Stage Parkinson's Disease (NCT01187966)Newron Pharmaceuticals SPA2007-01-01
Selegiline to Zelapar Switch Study in Parkinson Disease Patients (NCT00640159)Baylor College of Medicine2007-01-01
Trial to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine in Healthy Korean Subjects (NCT01964573)UCB Pharma2006-12-01
A Long-Term Extension Trial From Late Phase II of SPM 962 in Advanced Parkinson's Disease Patients (NCT01631812)Otsuka Pharmaceutical Co., Ltd.2006-12-01
An Exploratory, Randomized, Blinded, Placebo-Controlled Trial of Folic Acid and L-methylfolate in Parkinson's Disease (NCT00853879)Northwell Health2006-12-01
Motor Skill Learning in People With Parkinson's Disease (NCT00396942)National Institute of Neurological Disorders and Stroke (NINDS)2006-11-02
Efficacy and Safety of F-18 FPCIT PET in Parkinson's Disease and Essential Tremor Patients (NCT00468078)Asan Medical Center2006-11-01
PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets (NCT00491998)Vernalis (R&D) Ltd2006-11-01
Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations (NCT00360308)Eisai Limited2006-11-01
Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease Patients With Early Wearing-off (NCT00391898)Novartis2006-10-01
Medication Review in Patients on Anti-parkinson Therapy (NCT00443768)South Glasgow University Hospitals NHS Trust2006-10-01
Cellular Proteome From Leukocytes of Glaucoma Patients in Comparison With Patients With Parkinson's Disease (NCT00327301)University Hospital, Basel, Switzerland2006-10-01
A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease (NCT00399477)Teva Neuroscience, Inc.2006-10-01
Parcopa Versus Carbidopa-levodopa in a Single Dose Cross-over Comparison Study (NCT00590122)Baylor College of Medicine2006-10-01
A Study of E2007 as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations (NCT00360412)Eisai Inc.2006-10-01
Vitamin B12 Status and Response to Vitamin B12 Supplementation in Patients With Parkinson's Disease (NCT00208611)Emory University2006-09-01
Study to Evaluate Initiation of Stalevo in Early Wearing-off (NCT00462007)Orion Corporation, Orion Pharma2006-09-01
Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes (NCT00368199)Maastricht University Medical Center2006-09-01
Parkinson's Genes and Environment Study (NCT00367900)National Institute of Environmental Health Sciences (NIEHS)2006-08-21
PET Imaging in Parkinson Disease Dementia (NCT01052350)Washington University School of Medicine2006-08-01
Acamprosate for Treatment of Compulsive Behaviors and Craving in Parkinson's Disease (NCT00640952)Baylor College of Medicine2006-08-01
Physiological Brain Atlas Development (NCT00575081)Vanderbilt University Medical Center2006-08-01
Balance Training in Parkinson's Disease Using Cues (NCT01960985)University of Sao Paulo General Hospital2006-08-01
Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations (NCT00368108)Eisai Inc.2006-08-01
Sensory Cues for Freezing in Parkinson's Disease (NCT00322426)Austin Health2006-07-01
Continuous Application of Lisuride in Parkinson's Disease by Subcutaneous Infusion (NCT00408915)Axxonis Pharma AG2006-07-01
← Previous Next →

Track Parkinson's Disease automatically

Every clearance here is in the API, with alerts when new ones post.